Day 2 June 19(Fri)
09:00-10:00 |
Oral Presentation 1 [Clinical]
Room 1
|
- Chair(s)
-
Gun-Il Im (Dongguk University, Korea), Kyoung Min Kim (Yonsei University, Korea)
| 09:00-09:10 |
Osteonecrosis of the Jaw Risk With Antiresorptive Agents in Osteoporosis: A Target Trial Emulation Study
Kyoung Jin Kim (Korea University, Korea) |
| 09:10-09:20 |
Reduced Kidney Function Accelerates Muscle Strength but Not Mass Decline in Community-Dwelling Older Adults: A Prospective Cohort Study
Da Eun Kim (Seoul National University, Korea) |
| 09:20-09:30 |
Regional Skeletal Muscle Volume Phenotypes and Sex-Specific Vulnerability Profiles in the UK Biobank: A 27-Muscle MRI Segmentation Study
Hyeon Su Kim (Inha University, Korea) |
| 09:30-09:40 |
A Multicenter, Open-Label, Single-Arm Clinical Trial to Evaluate the Efficacy and Safety of Risedronate after Denosumab Discontinuation in Postmenopausal Osteoporosis Women
Jin Ah Park (Yonsei University, Korea) |
| 09:40-09:50 |
Independent, Combined, and Dose-Response Associations of Aerobic and Muscle-Strengthening Exercise with Fracture Risk: a Nationwide Population-Based Cohort Study
Chaiho Jeong (The Catholic University of Korea, Korea) |
| 09:50-10:00 |
Hip Fracture Incidence on Jeju Island Over 20 Years: Evidence of a Rightward Shift Toward the Oldest Age Groups
Changmin Choi (Jeju University, Korea) |
Day 2 June 19(Fri)
10:05-10:50 |
Plenary Lecture 1
Room 1
|
We are honored to welcome Professor Gustavo Duque from McGill University as our Plenary Speaker for SSBH 2026. A world-renowned pioneer in musculoskeletal geroscience, Professor Duque has redefined our understanding of aging by treating bone, muscle, and adipose tissue as a single, highly integrated physiological system. Moving beyond the view of these tissues as independent structures, he will present a transformative paradigm focusing on their complex and continuous synergy. The presentation will delve into the dual nature of these interactions, emphasizing both biochemical and mechanical crosstalk. Professor Duque will explain how these tissues function as endocrine organs, releasing a network of osteokines, myokines, and adipokines that coordinate systemic metabolic balance. Simultaneously, he will explore how they collectively sense and adapt to physical forces to maintain structural integrity. This integrated approach is crucial for understanding how their communication breakdown leads to age-related conditions such as osteosarcopenia. Attendees will gain invaluable insights into how restoring the balance within this "three-tissue system" can lead to more effective, holistic therapeutic strategies for the aging population.
- Chair(s)
-
Je-Yong Choi (Kyungpook National University, Korea)
| 10:05-10:50 |
Three Tissues, One System: The Bone–Muscle–Fat Connection
Gustavo Duque (McGill University, Canada) |
Day 2 June 19(Fri)
11:05-12:20 |
Symposium 1. New Perspectives on Antiresorptive Therapy
Room 1
|
This symposium aims to re-evaluate antiresorptive therapy from a new perspective. Although these agents have long been central to osteoporosis management, accumulating evidence calls for renewed attention to their evolving clinical implications.
The session opens with a timely discussion on denosumab discontinuation. Professor Albert Kim will review rebound bone resorption following denosumab withdrawal and its clinical relevance.
Next, Professor Tetsuya Seto will discuss the use of denosumab in patients undergoing hemodialysis, focusing on skeletal benefits and potential vascular risks.
Finally, Professor JeongHoon Ha will broaden the discussion by addressing the extra-skeletal effects of antiresorptive agents, encouraging reflection on their systemic impact beyond bone.
- Chair(s)
-
Seongbin Hong (Inha University, Korea), Seung Hun Lee ((Asan Medical Center,) University of Ulsan College of Medicine, Korea)
| 11:05-11:30 |
Understanding Rebound Bone Resorption After Denosumab Discontinuation
Albert Sungsoo Kim (University of Sydney, Australia) |
| 11:30-11:55 |
Denosumab in Hemodialysis: Bone Benefits and Vascular Risks
Tetsuya Seto (Washington University in St. Louis, USA) |
| 11:55-12:20 |
Beyond Bones: Extra-Skeletal Effects of Antiresorptives
Jeonghoon Ha (The Catholic University of Korea, Korea) |
Day 2 June 19(Fri)
12:20-12:35 |
Luncheon Symposium 1
Room 1
|
- Chair(s)
-
Ho-Yeon Chung (Kyung Hee University, Korea)
| 12:20-12:35 |
Optimizing the Sequential Treatment Journey in Osteoporosis
Beom-Jun Kim (University of Ulsan, Korea) |
Day 2 June 19(Fri)
12:35-12:50 |
Luncheon Symposium 2
Room 1
|
- Chair(s)
-
Deog Yoon Kim (Kyung Hee University, Korea)
| 12:35-12:50 |
Evolving Clinical Meaning of Bone Mineral Density in Osteoporosis: Insights from Stoboclo®
Yunkyung Jeon (Pusan National University, Korea) |
Day 2 June 19(Fri)
13:20-15:00 |
KSBMR-JSBMR Joint Symposium
Room 1
|
This joint symposium highlights the longstanding partnership between the Korean Society for Bone and Mineral Research (KSBMR) and the Japanese Society for Bone and Mineral Research (JSBMR). Bringing together leading clinicians and basic researchers from both nations, this session explores the evolving landscape of osteoporosis care and the latest breakthroughs in musculoskeletal biology.
From the clinical perspective, the symposium examines the 20-year evolution of osteoporosis treatment and post-fracture management in Korea, alongside a deep dive into rare metabolic bone disorders like acquired osteomalacia. On the scientific front, we delve into the plasticity of the musculoskeletal system in aging and the mechanisms of pathological bone formation in systemic diseases. We invite you to join this collaborative exchange that bridges clinical excellence and innovative research across Korea and Japan.
- Chair(s)
-
Sang Wan Kim (Seoul National University, Korea), Hiroshi Takayanagi (The University of Tokyo, Japan)
| 13:20-13:45 |
20-Year Landscape in Osteoporosis Management in South Korea: Treatment Patterns and Post-Fracture Management
Kyoung Jin Kim (Korea University, Korea) |
| 13:45-14:10 |
Prevalence of Undiagnosed Osteogenesis Imperfecta among Osteoporotic Patients and Genetic Type Predisposed to Valvular Disorder
Nobuaki Ito (The University of Tokyo, Japan) |
| 14:10-14:35 |
Exercise, Aging and the Plasticity of the Musculoskeletal System
Yong Ryoul Yang (KRIBB, Korea) |
| 14:35-15:00 |
Pathological Bone Formation in Cancer and Vascular Disease
Masayuki Tsukasaki (Showa Medical University, Japan) |
Day 2 June 19(Fri)
15:00-15:45 |
Plenary Lecture 2
Room 1
|
We are honored to host Professor Vicki Rosen as a plenary speaker for the SSBH. She is a renowned leader in skeletal biology and regenerative medicine and serves on the faculty of the Harvard School of Dental Medicine (HSDM). Her pioneering contributions have substantially advanced the field’s understanding of bone morphogenetic protein (BMP) signaling in bone development, skeletal stem cell biology, and tissue repair. Over the course of her career, Dr. Rosen has helped establish key conceptual links between BMP-mediated pathways and the regulation of skeletal homeostasis, with broad implications for aging, musculoskeletal disease, and regenerative therapeutics. In this session, Dr. Rosen will present recent advances on how BMP signaling governs skeletal stem cell differentiation, function, and long-term maintenance of bone integrity. Her talk is expected to integrate mechanistic insights with physiological and translational perspectives, highlighting how precise modulation of BMP pathways supports skeletal health across the lifespan. These insights are particularly timely as the field seeks strategies to combat age-related bone loss and improve regenerative outcomes. This presentation is anticipated to provide valuable guidance for researchers working in bone biology, stem cell regulation, and musculoskeletal medicine. Attendees will gain a deeper understanding of how BMP signaling can be leveraged to promote skeletal resilience and therapeutic innovation, potentially opening new avenues for interdisciplinary collaboration and translational research.
- Chair(s)
-
Chan Soo Shin (Seoul National University, Korea)
| 15:00-15:45 |
Harnessing BMP Signaling to Maintain a Healthy Skeleton Throughout Life
Vicki Rosen (Harvard School of Dental Medicine, USA) |
Day 2 June 19(Fri)
16:00-17:15 |
Symposium 3. Keynote Symposium
Room 1
|
This keynote symposium brings together three leading investigators to explore the rapidly expanding interface between immunology and skeletal biology. Dr. Hong-Hee Kim (Seoul National University) opens the session with a mechanistic investigation into how salt-inducible kinases regulate macrophage efferocytosis, shedding light on the inflammatory and bone-destructive pathways that drive joint damage in rheumatoid arthritis. Dr. Serk In Park (Korea University) then examines the immunological role of osteoblasts in the bone metastatic niche, revealing how these cells act as key orchestrators of bone marrow immunity and reshape the tumor microenvironment. The symposium concludes with Dr. A Ram Hong (Chonnam National University) addressing an urgent clinical challenge, skeletal complications arising from immune checkpoint inhibitor therapy, as immunotherapy becomes standard of care across a growing number of cancers. Together, these presentations illuminate the profound ways in which immune regulation and bone biology are intertwined, with implications spanning from bench to bedside.
- Chair(s)
-
Ha Young Kim (University of Ulsan, Korea), Je-Hwang Ryu (Chonnam National University, Korea)
| 16:00-16:25 |
Macrophage Efferocytosis Control by Salt-inducible Kinases: Implications for Inflammation and Bone Destruction in Rheumatoid Arthritis
Hong-Hee Kim (Seoul National University, Korea) |
| 16:25-16:50 |
Osteoimmunology of Bone Metastasis: Osteoblasts as Orchestrators of Bone Marrow Immunity
Serk In Park (Korea University, Korea) |
| 16:50-17:15 |
Skeletal Complications of Immune Checkpoint Inhibitors: A New Challenge
A Ram Hong (Chonnam National University, Korea) |